Can liver fibrosis be undone? Engitix, GSK aim to find out

New collaboration shifts the focus from slowing liver damage to understanding how scarred tissue may heal itself. “The global leader in ECM-based drug discovery and development, delivering life-changing therapies to patients with chronic diseases.” That’s how London-based biotech Engitix describes its mission. This week, the company took a significant step toward that ambition, announcing a […] The post Can liver fibrosis be undone? Engitix, GSK aim to find out appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.